Business Description
Pharmocann Global Ltd
ISIN : IL0010968902
Compare
Compare
Traded in other countries / regions
PMCN-M.Israel IPO Date
2006-05-16Description
Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.96 | |||||
| Equity-to-Asset | 0.11 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -23.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -44.2 | |||||
| 3-Year FCF Growth Rate | 13.6 | |||||
| 3-Year Book Growth Rate | -82.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.49 | |||||
| 9-Day RSI | 9.53 | |||||
| 14-Day RSI | 11.34 | |||||
| 6-1 Month Momentum % | -24.14 | |||||
| 12-1 Month Momentum % | -38.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 93.66 | |||||
| Days Sales Outstanding | 98.85 | |||||
| Days Payable | 61.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -50 | |||||
| Shareholder Yield % | 108.44 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -110.94 | |||||
| Operating Margin % | -190.79 | |||||
| Net Margin % | -210.24 | |||||
| FCF Margin % | -76.15 | |||||
| ROE % | -450.67 | |||||
| ROA % | -149.19 | |||||
| ROIC % | -394.29 | |||||
| ROC (Joel Greenblatt) % | -515.53 | |||||
| ROCE % | -342.87 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.11 | |||||
| PB Ratio | 2.92 | |||||
| Price-to-Tangible-Book | 3.03 | |||||
| EV-to-EBIT | -0.08 | |||||
| EV-to-EBITDA | -0.09 | |||||
| EV-to-Revenue | 0.18 | |||||
| EV-to-FCF | -0.32 | |||||
| Earnings Yield (Greenblatt) % | -1213.9 | |||||
| FCF Yield % | -281.96 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers